LCGC North America
What are the characteristics and relevant considerations for the development and validation of a stability-indicating method?
Anthony Wilken
Advertisement
Articles by Anthony Wilken
LCGC Europe
In the pharmaceutical industry, the demonstration of drug substance (DS) or drug product (DP) stability over the shelf life is an important aspect of the regulatory requirements.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on LCGC International
1
Chromatographic and Mass Spectrometric Screening of Novel Psychoactive Substances in Seized Drug Analysis
2
Industry Roundup: Bruker Unveils Next-Generation Multiomics MS Tools at ASMS
3
How AI and Machine Learning Are Reshaping Separations Science at HPLC 2026
4
HPLC Comparison of Dopamine in Parkinson's Therapy
5